Therefore, from a comprehensive and translational point of view, the effectiveness of pharmacologic inhibition of TLR4 by ATOR and other agents on the onset and progression of cancer cachexia, in particular the attenuation of the kinetics of tumor growth, still needs further study, especially in a clinical setting. Here, TLR4 is linked to neoplasm.